DEXCOM INC — Director's Dealing 2020

Mar 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-11

Reporting Person: Sylvain Jereme M (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-11	Common Stock	S	24	$250.1634	Disposed	14006	Direct
2020-03-11	Common Stock	S	589	$265.426	Disposed	13417	Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 11,247 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 3,216 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 2,548 of which were granted on November 8, 2018 and shall vest through November 8, 2021.